Insider · CIK 0001357865

Zorn Peter A

Reports to the SEC for 2 companies · WINSTON-SALEM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001357865

Forms 4 and 5

Insider transactions

46 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-08-21	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	Chief Corp. Officer, GC & Sec	AAward	+13K sh	—	—	13,000
2017-01-20	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	Chief Corp. Officer, GC & Sec	AAward	+20K sh	—	—	20,000
2016-11-03	ALBIREO PHARMA, INC.A Award	Chief Corp. Officer, GC & Sec	AAward	+934 sh	—	—	934
2016-11-03	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	Chief Corp. Officer, GC & Sec	AAward	+52.4K sh	—	—	52,441
2013-01-17	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	SVP, Lgl Affrs, GC & Secretary	AAward	+65K sh	—	—	65,000
2012-05-04	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	SVP, Lgl Affrs, GC & Secretary	AAward	+100K sh	—	—	100,000
2011-03-29	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	SVP, Lgl Affrs, GC & Secretary	AAward	+50K sh	—	—	50,000
2010-03-31	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	+313 sh	$5.10	+$1,596.3	313
2010-03-31	GYREGYRE THERAPEUTICS, INC.S Sale	SVP, Lgl Affrs, GC & Secretary	SSale	−313 sh	$19.41	−$6,075.33	0
2010-03-31	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	−313 sh	—	—	0
2010-01-19	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	SVP, Lgl Affrs, GC & Secretary	AAward	+50K sh	—	—	50,000
2009-12-31	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	+312 sh	$5.10	+$1,591.2	312
2009-12-31	GYREGYRE THERAPEUTICS, INC.S Sale	SVP, Lgl Affrs, GC & Secretary	SSale	−312 sh	$21.30	−$6,646.723	0
2009-12-31	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	+4,092 sh	$5.55	+$22.7K	4,092
2009-12-31	GYREGYRE THERAPEUTICS, INC.S Sale	SVP, Lgl Affrs, GC & Secretary	SSale	−4,092 sh	$21.02	−$86K	0
2009-12-31	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	−312 sh	—	—	313
2009-12-31	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	−4,092 sh	—	—	8,185
2009-10-22	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	+6,035 sh	$5.55	+$33.5K	6,035
2009-10-22	GYREGYRE THERAPEUTICS, INC.S Sale	SVP, Lgl Affrs, GC & Secretary	SSale	−6,035 sh	$20.64	−$125K	0
2009-10-22	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	−6,035 sh	—	—	12,277
2009-10-21	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	−4,375 sh	—	—	625
2009-10-21	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	+34.6K sh	$1.75	+$60.6K	34,611
2009-10-21	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	+4,375 sh	$5.10	+$22.3K	38,986
2009-10-21	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	+5,749 sh	$2.93	+$16.8K	44,735
2009-10-21	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	+47.2K sh	$5.55	+$262K	91,898
2009-10-21	GYREGYRE THERAPEUTICS, INC.S Sale	SVP, Lgl Affrs, GC & Secretary	SSale	−91.9K sh	$21.00	−$1.93M	0
2009-10-21	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	−34.6K sh	—	—	0
2009-10-21	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	−4,375 sh	—	—	0
2009-10-21	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	−47.2K sh	—	—	18,312
2009-10-21	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	−5,749 sh	—	—	40,251
2009-10-20	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	+908 sh	$5.10	+$4,630.8	908
2009-10-20	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	+3,555 sh	$5.63	+$20K	4,463
2009-10-20	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	+19.2K sh	$1.75	+$33.6K	23,650
2009-10-20	GYREGYRE THERAPEUTICS, INC.S Sale	SVP, Lgl Affrs, GC & Secretary	SSale	−23.7K sh	$21.40	−$506K	0
2009-10-20	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	−908 sh	—	—	0
2009-10-20	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	−995 sh	—	—	0
2009-10-20	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	−2,560 sh	—	—	0
2009-10-20	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	−3,840 sh	—	—	0
2009-10-20	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	−2,333 sh	—	—	0
2009-10-20	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	−5,625 sh	—	—	0
2009-10-20	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	−7,389 sh	—	—	34,611
2009-10-19	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	+5,800 sh	$5.10	+$29.6K	5,800
2009-10-19	GYREGYRE THERAPEUTICS, INC.S Sale	SVP, Lgl Affrs, GC & Secretary	SSale	−5,800 sh	$22.68	−$132K	0
2009-10-19	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	−4,375 sh	—	—	0
2009-10-19	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP, Lgl Affrs, GC & Secretary	MExercise/Conversion	−1,425 sh	—	—	908
2009-01-09	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	SVP, Lgl Affrs, GC & Secretary	AAward	+46K sh	—	—	46,000

Recent filings

Accepted (ET)
Aug 234
Zorn Peter A0001209191-17-049957
SEC(opens sec.gov)
Jan 244
ALBIREO PHARMA, INC.0001209191-17-005321
SEC(opens sec.gov)
Nov 74
ALBIREO PHARMA, INC.0001209191-16-148721
SEC(opens sec.gov)
Jan 184
Zorn Peter A0001140361-13-002532
SEC(opens sec.gov)
May 84
Zorn Peter A0001140361-12-023733
SEC(opens sec.gov)
Mar 314
Zorn Peter A0001140361-11-019850
SEC(opens sec.gov)
Apr 24
Zorn Peter A0001140361-10-015102
SEC(opens sec.gov)
Jan 214
Zorn Peter A0001140361-10-002239
SEC(opens sec.gov)
Jan 54
Zorn Peter A0001140361-10-000785
SEC(opens sec.gov)
Jan 54/A
Zorn Peter A0001140361-10-000776
SEC(opens sec.gov)
Oct 234
TARGACEPT INC0001140361-09-023766
SEC(opens sec.gov)

Companies

Address

C/O 200 EAST FIRST STREET, SUITE 300

WINSTON-SALEM, NC, 27101